An expert discusses how medical professionals have integrated tagraxofusp into blastic plasmacytoid dendritic cell neoplasm (BPDCN) treatment, leveraging its CD123-targeted efficacy per 0114 trial ...

Marlise R. Luskin, MD, MSCE, discussed treatment options for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and ...

The Naperville Unit District 203 school board will have at least two new faces after voters select four candidates to fill ...

She continued to counsel at Eugenia Hospital for over eight years. In 1998, Ms. Blastic joined Pennsylvania Hospital- Hall Mercer and continues to be the Director of the Dual Diagnosis ...